New research shows emotional impact of low sexual desire and associate... ( About the HSDD Patient Registry To...)

New research shows emotional impact of low sexual desire and associated distress

Date:2/18/2010

About the HSDD Patient Registry

To understand the natural course of HSDD in women, the New England Research Institutes in Watertown, Mass., is conducting the first-ever registry in female sexual health. The HSDD Registry for Women is a prospective, multicenter, observational study, which will provide data on the natural history and long-term consequences of HSDD.

"The HSDD Registry for Women is the first sexual medicine registry of its kind to investigate the history and clinical course of generalized, acquired Hypoactive Sexual Desire Disorder in women," said Ray Rosen, Ph.D., Chief Scientist of the New England Research Institutes. "With its in-depth analysis of medical co-morbidities, lifestyle factors and long-term outcomes, we expect the HSDD Registry to address a number of knowledge gaps surrounding HSDD in women."

Nearly one in 10 women report low sexual desire with associated distress, which may be HSDD, an often under-diagnosed condition that is defined as a decrease or lack of sexual desire that causes distress for the patient, may put a strain on relationships with partners, and is not due to the effects of a substance, including medications, or another medical condition.

"Many of the women I see with HSDD experience a high level of guilt and feelings of confusion," said Sheryl Kingsberg, Ph.D., President of ISSWSH, Chief of Behavioral Medicine at University Hospitals Case Medical Center, and professor in reproductive biology at Case Western Reserve University in Cleveland. "They also complain about the distance they feel between themselves and their partner. The emotional impact of HSDD is significant, so I am excited by the growing body of research being presented this year as it provides an in-depth look at this under-recognized but distressing condition."

The study and patient registry are supported by unrestricted grants through Boehringer Ingelheim Pharmaceuticals, Inc.

Ab
'/>"/>

Contact: Lara Crissey
lara.crissey@boehringer-ingelheim.com
203-798-4740
Ogilvy Public Relations
Source:Eurekalert

0

GOOD

Page: 1 2 3
Related medicine news :

1. Trade Privacy LLC: Research Concludes Apple Inc. Has Blocked Their Import Records from Public Access
2. Bersin & Associates Unveils Agenda for Research Conference, IMPACT 2010: The Business of Talent(R)
3. Researchers chart genomic map spanning over 2 dozen cancers
4. Dominos Pizza(R) Raises Record Amount for St. Jude Childrens Research Hospital
5. Attorney Joe Belluck Hails Department Of Defense For Increased Funding Of Mesothelioma Research
6. Researchers find biomarkers in saliva for detection of early-stage pancreatic cancer
7. Research validates surgery alone offers reasonable overall survival for stage I SCLC
8. Clemson researchers develop hands-free texting application
9. GUMC researchers say flower power may reduce resistance to breast cancer drug tamoxifen
10. Research finds hazards from secondhand smoke in bars and restaurants
11. UQ research shows canecutters disease on the rise among travelers

Post Your Comments:

(Date:5/18/2013)... FL (May 18, 2013) There are significant ... commonly used to diagnose or treat gastrointestinal problems, ... (DDW). , A study by New York ... more objective testing may substantially reduce the cost ... Although GERD is believed to affect nearly 25 ...

(Date:5/18/2013)... May 18, 2013 Today, Zane ... insurance agents’ role in Marketplaces . Zane Benefits, ... employer sponsored health benefits, is the leader in ... health reimbursement arrangements . , According to ... Human Services (HHS) recently released a much-anticipated statement ...

(Date:5/18/2013)... NY (PRWEB) May 18, 2013 After working ... efforts, SizeItUp formally announced the integration of the ... 2012 Hyundai Genesis is set to stun the automobile market ... style. 2012 Hyundai Genesis is marked as the latest entry ... heads the vehicles lined up for the year 2013. ...

(Date:5/18/2013)... AL (PRWEB) May 18, 2013 Although ... malignant tumors, the association between obesity and esophageal adenocarcinoma, ... for other obesity-related tumors. As reported on ... people are almost twice as likely as those of ... Although the relationship between obesity and esophageal cancer is ...

(Date:5/18/2013)... May 18, 2013 Show And Go Training, ... various different training systems that is all about is getting ... the attention of http://ShowAndGoTrainingReview.com ’s Stan Stevenson, prompting ... is a unique “four phase system” designed to make you ... of time spent working out in the gym. The training ...

Breaking Medicine News(10 mins):Health News:New research identifies practice changes to improve value and quality of GI procedures 2 Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 2 Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 3 Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 4 Health News:Renowned Rim Fitments Provider SizeItUp Launched Database Integrations for the 2012 Hyundai Genesis 2 Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 2 Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 3 Health News:Show And Go Training: Review Examining Eric Cressy's Workout Program Revealed 2

[0] New research identifies practice changes to improve value and quality of GI procedures [0] Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces [0] Renowned Rim Fitments Provider SizeItUp Launched Database Integrations for the 2012 Hyundai Genesis [0] hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer [0] Show And Go Training: Review Examining Eric Cressy's Workout Program Revealed

... for Everyone , Not all patients can tolerate ... can help physicians calculate the epirubicin dose associated with ... , Oncologists frequently use anthracyclines, including epirubicin and doxorubicin, ... lasting heart problems in a substantial number of patients. ...

... 6.9 percent sequentially - Q2 GAAP net profit ... - Case shipments of 54,870 increase 6.0 percent sequentially ... SANTA CLARA, Calif., July 29 Align,Technology, Inc. (Nasdaq: ALGN ... ended June 30, 2008., Total net revenues for the second ...

... projected ... ... of,high-quality ceramic solutions for the medical device industry, announced,today that, in ... on unit shipments to the orthopaedic,brachytherapy and electro-implantable market segments., ...

... FACP, FACEP (E), Executive,Director, American Public Health Association, ... Association strongly urges U.S. House members to vote ... Food and Drug Administration (FDA),the authority to regulate ... for more than 400,000 deaths each,year and costs ...

... of matted protein, researchers say , , TUESDAY, July 29 (HealthDay ... clogging "tangles" in the brain cells of people with Alzheimer,s ... studies are necessary to confirm whether the medication is as ... needs to be given as part of a cocktail of ...

... ... Future Costs Can Be Avoided with Proper Treatment and Prevention ... Initiatives, NEW BRUNSWICK, N.J., ... on New,Jersey,s economy of the most common chronic diseases is calculated to be,$39 billion. In ...

Also in the July 29 JNCI Align Technology Announces Second Quarter Fiscal 2008 Results C5 Medical Werks Reaches Million Mark in Components Shipped APHA Urges House to Protect Health of Americans by Passing Tobacco Legislation 'De-Tangling' Alzheimer's Drug Shows Promise Annual Economic Impact of Chronic Disease on New Jersey Economy Is $39 Billion

(Date:5/17/2013)... 17, 2013 Orexigen® Therapeutics, Inc. (Nasdaq: OREX ... at the UBS Global Healthcare Conference in New ... 22 nd at 11 a.m. Eastern Time. To listen ... please visit the Investor Relations section of the Company,s Web ... for 14 days after the event. About Orexigen® ...

(Date:5/17/2013)... Biotechnology Inc. ("Sony") today announced the launch of the new ... Sony will also be exhibiting its newly rebranded reagent portfolio. ... EC800 flow cytometer, and new SP6800 Spectral Analyzer will be ... held at the San Diego Convention ... May 20 - 22. The 8-well strip ...

(Date:5/17/2013)... Research explores data on ... also to be presented ... the global specialty biopharmaceutical company, announces that it will ... American Psychiatric Association (APA) 166th Annual Meeting in ... being presented represent Shire,s ongoing commitment to the clinical ...

[0] Orexigen Therapeutics to Present at the UBS Global Healthcare Conference [0] Sony Delivers New Technology for Science to CYTO 2013 [0] Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting

... increasingly are applying genomics technologies to toxicology research to ... a variety of organ systems, reports Genetic Engineering ... especially interested in figuring out a new compound,s mechanism ... according to the November 15 issue of GEN ...

... Nov. 18 Arlington Medical Resources (AMR), a,provider of ... finds that over $10 million of CSL Behring,s Privigen ... 2008. Privigen is the newest,brand of intravenous immune globulin ... IVIG is a product created from the blood plasma ...

Cached Medicine Technology:GEN Reports on the Trend Toward Predictive Toxicogenomics 2 Over $10 Million of CSL Behring's Privigen Was Sold in the U.S. During the Third Quarter of 2008 2

GEN Reports on the Trend Toward Predictive Toxicogenomics Over $10 Million of CSL Behring's Privigen Was Sold in the U.S. During the Third Quarter of 2008

Classic Trial Frames UB3 that has long set the standard....

... This quality Universal Trial Frame comes at a very attractive ... Temple angle, Temple length 4 1/8" to 5 1/2" ... angle 0 to 30, PD adjustable 24 to 40mm ... Axial calibration on each lens: left - 120 to 0 ...

Sickle blade. Flat stock myringotomy blade....

... offer the superior cutting advantages of ... the exclusive Rib-Back design for greater ... producer offer the wide selection of ... Every blade is packaged in a ...

Medicine Products:

Classic Trial Frames UB3 Adult Trial Frame Sickle Blade Rib Back